Recruiting

Cold Atmospheric Plasma

Sponsor:

The Skin Center Dermatology Group

Code:

NCT02759900

Conditions

Actinic Keratosis

Acne/Rosacea

Verruca Plana

Tinea

Molluscum Contagiosum

Eligibility Criteria

Sex: All

Age: 4+

Healthy Volunteers: Not accepted

Interventions

Non-thermal, atmospheric plasma to treat skin lesions and acne

Indirect non-thermal, atmospheric plasma to treat hair loss and acne

Study Details

Brief summary:

This study examines the efficacy of a non-thermal, atmospheric plasma device in the treatment of skin disorders

Conditions

Actinic Keratosis

Acne/Rosacea

Verruca Plana

Tinea

Molluscum Contagiosum

Study ID

NCT02759900

Start date

Jan, 2016

Status verified date

Apr, 2022

Completion date

Jan, 2025

Anticipated

Primary completion date

Mar, 2024

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 4+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • diagnoses of target conditions
  • ability to complete study protocol

Exclusion Criteria:

  • based on specific condition

Study Design

Enrollment

100 participants

Anticipated

Allocation

Non randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Non-thermal atmospheric plasma treatment

Device treatment

experimental: Indirect non-thermal atmospheric plasma treatment

A compound of non-thermal atmospheric plasma and medium is used to treat the target by direct application or by on-site generation of the compound

Interventions

Non-thermal, atmospheric plasma to treat skin lesions and acne

Non-thermal, atmospheric plasma treatment of affected area or lesions using a nanosecond dielectric barrier discharge plasma device

Indirect non-thermal, atmospheric plasma to treat hair loss and acne

A compound of non-thermal, atmospheric plasma and medium is delivered to or generated at the target area. Plasma is generated using either microsecond dielectric barrier discharge plasma device or PiezoBrush (a helium jet plasma). The medium is an aqueous alcohol solution

Primary outcome measure

  • Clinical improvement [ Time Frame: 1-12 months ]

Central Contacts and Locations

Locations

The Skin Center Dermatology Group

Recruiting

New City, New York, United States, 10956

Contacts

Peter C Friedman, MD, PhD

845-352-0500pbc9@columbia.edu

More Information

Sponsor

The Skin Center Dermatology Group

Last update posted

Apr 12, 2022

Last verified

Apr, 2022

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by The Skin Center Dermatology Group on 2022-04-12.